###begin article-title 0
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 58 63 <span type="species:ncbi:9606">Human</span>
Leptin Enhances Synthesis of Proinflammatory Mediators in Human Osteoarthritic Cartilage-Mediator Role of NO in Leptin-Induced PGE2, IL-6, and IL-8 Production
###end article-title 0
###begin p 1
Recommended by Jan van Amsterdam
###end p 1
###begin p 2
###xml 538 539 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 675 680 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 686 691 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 754 755 746 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 928 929 920 921 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1049 1050 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 396 401 <span type="species:ncbi:9606">human</span>
Obesity is an important risk factor for osteoarthritis (OA) in weight-bearing joints, but also in hand joints, pointing to an obesity-related metabolic factor that influences on the pathogenesis of OA. Leptin is an adipokine regulating energy balance, and it has recently been related also to arthritis and inflammation as a proinflammatory factor. In the present paper, the effects of leptin on human OA cartilage were studied. Leptin alone or in combination with IL-1 enhanced the expression of iNOS and COX-2, and production of NO, PGE2, IL-6, and IL-8. The results suggest that the effects of leptin are mediated through activation of transcription factor nuclear factor kappaB (NF-kappaB) and mitogen-activated protein kinase (MAPK) pathway c-Jun NH2-terminal kinase (JNK). Interestingly, inhibition of leptin-induced NO production with a selective iNOS inhibitor 1400 W inhibited also the production of IL-6, IL-8, and PGE2, and this was reversed by exogenously added NO-donor SNAP, suggesting that the effects of leptin on IL-6, IL-8, and PGE2 production are dependent on NO. These findings support the idea of leptin as a factor enhancing the production of proinflammatory factors in OA cartilage and as an agent contributing to the obesity-associated increased risk for osteoarthritis.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
Leptin is a hormone that was initially found to be synthesized by white adipocytes and has a strong correlation with the amount of adipose tissue and with body mass index (BMI). Leptin was first discovered in 1994 and found to act as a signal for the central nervous system to inhibit food intake and to stimulate energy expenditure [1]. More recent findings on the ubiquitous expression of leptin receptors in almost all tissues and on its cellular effects have revealed that leptin is also involved in the regulation of a variety of biological functions related to immune responses and inflammatory diseases, and to cardiovascular and respiratory pathophysiology [2-5].
###end p 4
###begin p 5
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 942 943 942 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
###xml 932 940 <span type="species:ncbi:9606">patients</span>
Obesity is an important risk factor for osteoarthritis (OA) [6]. Increased joint loading and altered mechanic loading axis has been proposed to explain the increased risk of OA in weight-bearing joints, including hip and knee joints. Surprisingly, there is also a positive association between obesity and OA in the hand, pointing to an obesity related metabolic factor that acts as a risk factor for OA. Recently, it has been shown that synovial fluid (SF) from OA patients contains leptin concentrations that are similar or higher than those measured in serum [7-9]. Furthermore, low soluble leptin receptor (sOb-R) level in SF potentiates the biological activity of leptin in the joint as compared to that in serum [8]. Articular cartilage has been reported to produce leptin [8, 10] and express functional leptin receptor Ob-R [11], and the expression of these two is further increased in advanced OA correlating with BMI of the patients [9].
###end p 5
###begin p 6
###xml 82 87 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 92 97 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 222 224 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 226 228 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 350 354 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 444 445 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 447 449 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 601 603 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 752 756 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 761 765 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 822 823 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 424 429 <span type="species:ncbi:9606">human</span>
###xml 581 586 <span type="species:ncbi:9606">human</span>
###xml 637 640 <span type="species:ncbi:10116">rat</span>
In vitro, leptin has been shown to potentiate interleukin-1 (IL-1) and interferon gamma (IFNgamma)-induced production of nitric oxide (NO) in chondrocytes, which is a proinflammatory and destructive mediator in cartilage [12, 13]. Leptin has been shown to decrease chondrocyte proliferation and to increase production of proinflammatory cytokine IL-1beta and destructive matrix metalloproteinases 9 and 13 (MMP-9 and 13) in human chondrocytes [9, 14]. On the other hand, leptin has also been reported to increase proliferation and to enhance proteoglycan and collagen synthesis in human chondrocytes [11]. In vivo, leptin injection into rat knee was reported to increase synthesis of insulin-like growth factor 1 (IGF-I) and transforming growth factor beta (TGFbeta) both contributing to increased proteoglycan synthesis [7]. These effects are linked to increased cartilage matrix production, and also to osteophyte formation.
###end p 6
###begin p 7
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
NO is related to the pathogenesis of OA as a destructive mediator [15]. Inducible nitric oxide synthase (iNOS) is expressed in OA cartilage, and there are markers of enhanced NO production in OA joints [15, 16]. Prostaglandins (PGs), especially PGE2, mediate inflammation, tissue destruction, and pain in OA and in OA joints they are formed by cyclooxygenase (COX) enzymes (particularly COX-2) and prostaglandin synthases [17]. Interleukin-6 (IL-6) and interleukin-8 (IL-8) are produced by OA cartilage and have a proinflammatory and modulatory role in the pathogenesis of OA [10, 18].
###end p 7
###begin p 8
###xml 308 309 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The presence of bioactive leptin in OA joint and the effects of leptin on cartilage metabolism point to a pathophysiological role for leptin in OA. The aim of the present study was to investigate the effects of leptin on mediators of cartilage metabolism by measuring its effects on the production of NO, PGE2, IL-6, and IL-8 in OA cartilage and by evaluating the signaling mechanisms involved in these effects by pharmacological means.
###end p 8
###begin title 9
2. Materials and Methods
###end title 9
###begin title 10
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
2.1. Patients and Cartilage Cultures
###end title 10
###begin p 11
###xml 177 185 <span type="species:ncbi:9606">patients</span>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
Cartilage tissue was obtained from the leftover pieces of total knee replacement surgery. The study was approved by the Ethics Committee of Tampere University Hospital, and the patients gave their written approval. The donor patients, age ranging from 53 to 87 years and body mass index ranging from 20 to 32, were all diagnosed to have osteoarthritis.
###end p 11
###begin p 12
###xml 703 705 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 644 650 <span type="species:ncbi:9913">bovine</span>
Cartilage samples were washed with phosphate buffered saline (PBS) and processed for the experiments within two hours after the operation. Full thickness pieces of articular cartilage from femoral condyles, tibial plateaus, and patellar surfaces showing macroscopical features of early OA were removed aseptically from subchondral bone with a scalpel and cut into small pieces (about 2 x 2 x 2 mm). Cartilage cubes randomly selected from 3 different areas of the joint were incubated in one well of a 6-well plate in 3 mL of tissue culture medium (Dulbecco's modified Eagle's medium (DMEM) with glutamax-I containing 10% heat-inactivated fetal bovine serum, penicillin (100 units/mL), streptomysin (100 mug/mL), and amphotericin B (250 ng/mL); all obtained from Invitrogen, Carlsbad, Calif, USA)) at 37degreesC in humidified 5% carbon dioxide atmosphere.
###end p 12
###begin p 13
###xml 110 112 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 123 125 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 164 168 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 219 220 214 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 371 373 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 384 386 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 425 429 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 630 631 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 778 780 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 842 844 831 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 876 878 864 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 908 910 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 941 943 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 975 977 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 1010 1012 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 1040 1042 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 1048 1053 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1079 1081 1057 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 1087 1092 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1131 1132 1104 1105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1263 1265 1236 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 1290 1291 1262 1263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1668 1670 1640 1641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 1757 1758 1728 1729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 725 733 <span type="species:ncbi:9606">patients</span>
###xml 1465 1473 <span type="species:ncbi:9606">patients</span>
In the first two series of experiments, OA cartilage explants from 8 patients were incubated with leptin (0.1 mug/mL or 10 mug/mL) alone or in combination with IL-1beta (10 pg/mL) for 48 hours. Concentrations of NO, PGE2, IL-6, and IL-8 were determined in the culture medium. In the third series of experiments OA explants from 3 patients were incubated with leptin (0.1 mug/mL or 10 mug/mL) alone or in combination with IL-1beta (10 pg/mL) for 48 hours. Cartilage samples were used to determine expression of iNOS and COX-2 protein. In the fourth series of experiments, signaling mechanisms involved in the leptin-induced NO, PGE2, IL-6, and IL-8 production were studied using pharmacological inhibitors. OA explants from 7 patients were incubated for 48 hours with leptin (10 mug/mL) and following signaling pathway inhibitors: SP600125 10 muM (JNK inhibitor), SB220025 0.5 muM (p38 inhibitor), PD98059 10 muM (Erk1/2 inhibitor), AG490 10 muM (JAK2 inhibitor), WHI-P154 10 muM (JAK3 inhibitor), Ro 31-8220 1 muM (PKC inhibitor), MG132 10 muM (NF-kappaB inhibitor), and PDTC 10 muM (NF-kappaB inhibitor). Concentrations of NO, PGE2, IL-6, and IL-8 were determined in the culture medium. In the fifth series of experiments, the effect of NO on leptin-induced (10 mug/mL) IL-6, IL-8, and PGE2 production was studied by inhibiting leptin-induced endogenous NO production with a selective iNOS inhibitor 1400 W (1 mM) during a 48 hour incubation of OA explants from 8 patients. The effect of NO was further investigated by studying if exogenous NO could reverse the effects of iNOS inhibitor 1400 W in leptin-treated cartilage. This was made by adding NO-donor SNAP (100 muM) together with 1400 W and leptin in the cartilage cultures. Concentrations of NO, PGE2, IL-6, and IL-8 were determined in the culture medium.
###end p 13
###begin p 14
After the experiment the cartilage explants were weighed, and the results were expressed per mg of cartilage. Aliquots of the culture media were kept at -20degreesC until assayed, and cartilage samples for Western blotting were first snap frozen in liquid nitrogen and analysed as described below.
###end p 14
###begin title 15
2.2. NO Production
###end title 15
###begin p 16
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Concentrations of nitrite, a stable product of NO in aqueous solutions, were measured using the Griess reaction [19]. The results were expressed as pmol of nitrite/mg of cartilage.
###end p 16
###begin title 17
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
2.3. Prostaglandin E2 Assays
###end title 17
###begin p 18
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 197 198 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The amount of PGE2 released into the incubation medium was determined by radioimmunoassay, using reagents from the Institute of Isotopes (Budapest, Hungary). The results were expressed as pg of PGE2/mg of cartilage.
###end p 18
###begin title 19
2.4. IL-6 and IL-8 Assays
###end title 19
###begin p 20
The concentrations of IL-6 (Sanquin, PeliPair, Amsterdam, The Netherlands) and IL-8 (R&D Systems, Minneapolis, MN, USA) in the culture medium were determined by ELISA. The results were expressed as pg of IL-6/mg of cartilage, or pg of IL-8/mg of cartilage.
###end p 20
###begin title 21
2.5. Western Blot Analysis
###end title 21
###begin p 22
###xml 247 249 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 268 270 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 336 338 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 576 580 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 718 720 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 758 760 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 1010 1016 <span type="species:ncbi:9986">rabbit</span>
###xml 1041 1046 <span type="species:ncbi:9606">human</span>
###xml 1056 1060 <span type="species:ncbi:9925">goat</span>
###xml 1085 1090 <span type="species:ncbi:9606">human</span>
###xml 1217 1223 <span type="species:ncbi:9986">rabbit</span>
After incubations, the cartilage specimen were snap frozen in liquid nitrogen, milled and lysed in extraction buffer (10 mM Tris-HCl, 5 mM EDTA, 50 mM NaCl, 1% Triton-X-100, 0.5 mM phenylmethylsulfonylfluoride (PMSF), 1 mM sodiumorthovanadate, 20 mug/mL leupeptin, 50 mug/mL aprotin, 5 mM sodium fluoride, 2 mM sodium pyrophosphate, 10 muM n-octyl-beta-D-glucopyranoside). Following incubation on ice for 15 minutes, samples were centrifuged and supernatants were mixed with sample buffer 1 : 4 (62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 0.025% bromophenol blue, and 5% beta-mercaptoethanol) and stored at -20degreesC until analyzed. Coomassie blue method was used to measure the protein content of the samples [20]. After boiling, protein samples (20 mug) were separated with 8% SDS-polyacrylamide electrophoresis gels and transferred to Hybond enhanced chemiluminescence nitrocellulose membrane (Amersham Biosciences UK Limited, Buckinghamshire, UK). Proteins were identified by Western blotting using rabbit polyclonal antibody for human iNOS and goat polyclonal antibody for human COX-2 (both obtained from Santa Cruz Biotechnology, Santa Cruz, Calif, USA). Actin was analysed as a loading control by using rabbit polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, Calif, USA). Bound antibody was detected using SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, IL, USA) and FluorChem 8800 imaging system (Alpha Innotech, San Leandro, Calif, USA). Quantitation of the chemiluminescent signal was carried out with FluorChem software v.3.1.
###end p 22
###begin title 23
2.6. Statistical Analysis
###end title 23
###begin p 24
###xml 139 140 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Results are expressed as mean +/- standard error of the mean (SEM). Statistical significance of the results was calculated by using paired t-test.
###end p 24
###begin title 25
2.7. Materials
###end title 25
###begin p 26
###xml 162 164 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 12 17 <span type="species:ncbi:9606">Human</span>
###xml 41 46 <span type="species:ncbi:9606">Human</span>
Recombinant Human Leptin and Recombinant Human IL-1 beta were purchased from R&D Systems; manufacturer ensures low endotoxin level of the products (<1.0 EU per 1 mug of the recombinant protein), and that amount in relation to the leptin concentrations used in the present study was tested to have no effect in our tissue culture conditions. Other reagents were obtained as follows: SP600125, SB220025, AG 490 and WHI-P154 were from Calbiochem (Merck, Darmstadt, Germany); PD 98059 was from Promega (Madison, WI, USA); Ro 31-8220 was from Alexis Corporation (Lausen, Switzerland); MG 132 was from Tocris Bioscience (Ellisville, MO, USA); PDTC was from Sigma Chemical Co (St Louis, MO, USA); SNAP was from Cayman Chemical (Ann Arbor, MI, USA). 1400 W was kindly given by Dr Richard G Knowles, Glaxo SmithKline Research & Development, Stevenage, UK.
###end p 26
###begin title 27
3. Results
###end title 27
###begin title 28
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 69 74 <span type="species:ncbi:9606">Human</span>
3.1. The Effects of Leptin on NO, PGE2, IL-6, and IL-8 Production in Human OA Cartilage
###end title 28
###begin p 29
###xml 12 14 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 26 28 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 101 112 99 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(a)</xref>
###xml 185 187 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 252 263 249 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(b)</xref>
###xml 290 292 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 311 312 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 433 437 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(c)</xref>
###xml 439 443 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(d)</xref>
###xml 445 449 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(e)</xref>
###xml 455 459 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(f)</xref>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 378 383 <span type="species:ncbi:9606">human</span>
Leptin (0.1 mug/mL and 10 mug/mL) enhanced NO production in OA cartilage in a dose-dependent manner (Figure 1(a)). Western blot analysis with human iNOS antibody showed that leptin (10 mug/mL) induced also iNOS expression in cultured cartilage tissue (Figure 1(b)). In addition, leptin (10 mug/mL) increased PGE2 production and COX-2 expression, and IL-6 and IL-8 production in human OA cartilage during 48 hours incubation (Figures 1(c), 1(d), 1(e), and 1(f)).
###end p 29
###begin p 30
###xml 52 56 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 110 111 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 170 178 167 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 192 194 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 216 217 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 320 324 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 326 334 319 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
A low concentration of proinflammatory cytokine IL-1beta (10 pg/mL) had a slight stimulatory effect on NO, PGE2, IL-6, and IL-8 production and iNOS and COX-2 expression (Figure 2). Leptin (10 mug/mL) enhanced NO, PGE2, IL-6, and IL-8 production, and iNOS and COX-2 expression in OA cartilage also in the presence of IL-1beta (Figure 2).
###end p 30
###begin title 31
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
3.2. Signaling Mechanisms Involved in the Leptin-Induced NO, PGE2, IL-6, and IL-8 Production
###end title 31
###begin p 32
###xml 121 126 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 157 158 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 278 283 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 297 299 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 316 318 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 353 355 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 404 405 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 434 442 423 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 560 562 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 600 602 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 633 634 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 724 726 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 768 769 754 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 833 835 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 888 889 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1024 1026 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 1059 1060 1043 1044 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The involvement of signaling pathways (JNK, p38, and Erk1/2 MAP-kinases, JAK2 and JAK3, PKC, and transcription factor NF-kappaB) in leptin-stimulated NO, PGE2, IL-6, and IL-8 production in OA cartilage was studied by pharmacological means. Inhibitors of transcription factor NF-kappaB, MG 132 (10 muM) and PDTC (100 muM), and JNK inhibitor SP600125 (10 muM) significantly inhibited leptin-induced NO, PGE2, IL-6, and IL-8 production (Figure 3). In addition to the effect of JNK inhibitor, inhibitors of other MAP-kinases, that is, SB220025 (p38 inhibitor; 0.5 muM) and PD 98059 (Erk1/2 inhibitor; 10 muM) inhibited leptin-induced PGE2 production, but had no effect on NO, IL-6, or IL-8 production. JAK2 inhibitor AG 490 (10 muM) had no effect on leptin-induced NO, PGE2, IL-6, or IL-8 production, whereas JAK3 inhibitor WHI-P154 (10 muM) inhibited leptin-induced NO synthesis, but not PGE2, IL-6, or IL-8 production. Leptin-induced NO, IL-6, and IL-8 production was inhibitable with protein kinase C inhibitor Ro 31-8220 (1 muM), while it had no effect on PGE2 production.
###end p 32
###begin title 33
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
3.3. The Effect of NO on Leptin-Induced IL-6, IL-8, and PGE2 Production
###end title 33
###begin p 34
###xml 155 166 155 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4(a)</xref>
###xml 274 275 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">4(b)</xref>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">4(d)</xref>
###xml 355 357 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 469 470 468 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 485 490 <span type="species:ncbi:9606">human</span>
A selective iNOS inhibitor 1400 W (1 mM) inhibited leptin-induced NO production almost completely indicating that it was synthesized through iNOS pathway (Figure 4(a)). Interestingly, inhibition of NO production with 1400 W reduced also the production of IL-6, IL-8, and PGE2 (Figures 4(b)-4(d)). The effect of 1400 W was reversed when NO-donor SNAP (100 muM) was added into the culture. Those results suggest that the increasing effect of leptin on IL-6, IL-8, and PGE2 production in human OA cartilage is dependent on NO.
###end p 34
###begin title 35
4. Discussion
###end title 35
###begin p 36
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 596 597 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 675 676 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 617 622 <span type="species:ncbi:9606">human</span>
Osteoarthritis is a chronic disease characterised by gradual loss of the articular cartilage. The course of the destructive process is determined by the balance between anabolic and catabolic mediators and their regulators in the joint, and the local distribution of these mediators in the cartilage [18]. Leptin is an obesity related mediator, which has been suggested to take part in the regulation of anabolic and catabolic processes within the osteoarthritic joint and to play a role in the pathogenesis of OA [21]. In the present study, we found that leptin induced the production of NO, PGE2, IL-6, and IL-8 in human osteoarthritic cartilage and that leptin-induced PGE2, IL-6, and IL-8 production was dependent on NO. These findings support the role of leptin in the pathogenesis of OA.
###end p 36
###begin p 37
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 428 432 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 434 436 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 512 514 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 516 518 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 520 522 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 598 600 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 654 659 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 703 708 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 727 729 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 882 884 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1013 1015 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1052 1054 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1120 1122 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1378 1380 1367 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 876 880 <span type="species:ncbi:9615">dogs</span>
###xml 1269 1273 <span type="species:ncbi:10090">mice</span>
NO mediates many of the destructive effects of IL-1 in inflamed joints [15, 16]. NO has been reported to increase the production of matrix metalloproteinases (MMPs) and to activate them [10, 22, 23], to inhibit proteoglycan [24-26] and collagen [27] synthesis and to induce chondrocyte cell death [28, 29]. NO is also involved in the progress of inflammation by reducing the production of anti-inflammatory/anabolic factors TGF-beta [30], endogenous IL-1 receptor antagonist (IL-1ra), and IL-10 in chondrocytes [10, 31, 32], and by contributing to the resistance against anabolic effects of IGF-1 [33]. NO has also been shown to sustain activation of NF-kappaB providing a prolonged transcription of NF-kappaB dependent genes [34]. In support, Pelletier et al. reported reduced destruction of the articular cartilage by using iNOS-inhibitor L-NIL in instability-induced OA in dogs [35]. In further studies with this model, L-NIL was shown to reduce the levels of matrix metalloproteinase-1 and -3 (MMP-1 and -3) [23], to inhibit chondrocyte apoptosis [36] and to reduce the interleukin-1 converting enzyme (ICE) levels [37]. Van den Berg et al. studied the development of experimental osteoarthritis induced with intra-articular collagenase injection in iNOS knock-out mice. In this model, iNOS deficiency prevented the degree of cartilage destruction and osteophyte formation [38]. NO has several catabolic and antianabolic actions in cartilage and thus it is identified as a possible target of treatment in osteoarthritis.
###end p 37
###begin p 38
###xml 74 79 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 84 89 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 119 124 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 129 134 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 147 152 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 161 165 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 295 297 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 298 300 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 393 398 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 403 408 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 436 438 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 440 442 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 663 667 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 677 681 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(a)</xref>
###xml 683 687 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(b)</xref>
###xml 693 697 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(a)</xref>
###xml 699 703 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(b)</xref>
###xml 184 190 <span type="species:ncbi:10090">murine</span>
###xml 212 215 <span type="species:ncbi:10116">rat</span>
###xml 253 256 <span type="species:ncbi:10116">rat</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 560 565 <span type="species:ncbi:9606">human</span>
Leptin has been shown to induce or to potentiate together with interferon gamma (IFNgamma), with tumor necrosis factor alpha (TNFalpha) or with IFNgamma and IL-1beta, NO production in murine J774A.1 macrophages, rat adipocytes, C6 glioma cell-line, and rat vascular smooth muscle cells (VSMCs) [39-42]. In human chondrocytes, leptin was reported to enhance interleukin-1 (IL-1) and interferon gamma (IFNgamma)-induced production of NO [12, 13]. In the present study, we showed that leptin alone is sufficient to induce the iNOS expression and NO production in human OA cartilage, and an enhancing effect was seen also in the presence of low concentrations of IL-1beta (Figures 1(a), 1(b), and 2(a), 2(b)).
###end p 38
###begin p 39
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 465 470 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 472 474 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 475 477 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 658 660 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 662 664 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 763 764 759 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 850 854 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(c)</xref>
###xml 856 861 852 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(d) </xref>
###xml 865 869 861 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(c)</xref>
###xml 871 875 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(d)</xref>
###xml 925 926 921 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1032 1034 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1036 1038 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 779 784 <span type="species:ncbi:9606">human</span>
###xml 1004 1010 <span type="species:ncbi:10090">murine</span>
Prostaglandins (especially PGE2) are produced in high amounts in OA cartilage and are modulators of inflammation, tissue destruction, and inflammatory pain. Prostaglandins are formed from arachidonic acid by the prostaglandin synthesizing cyclooxygenase (COX) enzymes and prostaglandin synthases [17]. COX-2 is highly expressed in OA cartilage and is induced by various cytokines that are involved in destructive processes in OA cartilage, for example, IL-1 and TNFalpha [43-45]. Current drug therapy of OA is based on nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs inhibit COX enzymes and prostanoid production, and they are used to relieve OA pain [46, 47]. To our knowledge, we show here for the first time that leptin increases COX-2 expression and PGE2 production in human OA cartilage in the absence and in the presence of IL-1 (Figures 1(c), 1(d) and 2(c), 2(d)). Previously, leptin has been shown to induce PGE2 production in OE33 Barret's esophageal adenocarcinoma (EAC) cell-line and in murine J774A.1 macrophages [39, 48].
###end p 39
###begin p 40
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 281 285 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 293 298 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 415 417 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 507 512 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 567 569 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 571 573 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 574 576 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 705 709 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(e)</xref>
###xml 711 716 700 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(f) </xref>
###xml 721 725 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(e)</xref>
###xml 727 731 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(f)</xref>
###xml 900 902 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 903 905 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1008 1010 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 385 390 <span type="species:ncbi:9606">human</span>
###xml 677 682 <span type="species:ncbi:9606">human</span>
###xml 796 801 <span type="species:ncbi:9606">human</span>
###xml 819 824 <span type="species:ncbi:9606">human</span>
###xml 836 841 <span type="species:ncbi:9606">human</span>
###xml 944 949 <span type="species:ncbi:9606">human</span>
Proinflammatory and regulatory cytokines IL-6 and IL-8 are found in SF from OA patients [49]. OA cartilage produces IL-6 and IL-8, and quantitative RT-PCR studies have shown elevated IL-6 and IL-8 mRNA levels in OA cartilage as compared to normal cartilage [10, 50]. Cytokines IL-1beta and TNFalpha which induce destructive effects in cartilage both induce IL-6 and IL-8 production in human articular chondrocytes [51]. IL-6 and IL-8 may promote inflammation and cartilage destruction induced by IL-1 or TNFalpha and have a modulatory role in the pathogenesis of OA [18, 52-54]. In the present study, we show for the first time that leptin enhances IL-6 and IL-8 production in human OA cartilage (Figures 1(e), 1(f)  and 2(e), 2(f)). Leptin has previously been shown to induce IL-6 production in human dendritic cells, human monocytes, human endometrial stromal cells (ESC), and in epithelial cells [55-57], and to stimulate IL-8 production in human endometrial stromal cells (ESCs) and in epithelial cells [56].
###end p 40
###begin p 41
###xml 318 323 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 329 334 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 428 429 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 431 433 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 585 590 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 637 639 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 641 643 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 645 647 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 848 853 836 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 889 890 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1182 1187 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1214 1215 1194 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1316 1321 1296 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1410 1415 1386 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1418 1426 1390 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
Leptin signaling through leptin receptors (Ob-R) is thought to be mediated through janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway and in addition to this, also mitogen-activated protein kinases (MAPKs), protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3K), and nuclear factor kappaB (NF-kappaB) pathways have been reported to mediate some effects of leptin, depending on the cell type [3, 58]. In chondrocytes, Otero et al. showed by using pharmacological inhibitors that induction of NO production with a combination of leptin and IL-1 or IFNgamma was dependent on JAK2, PI3K, Erk1/2, and p38 [12, 13, 59], but these studies did not show signaling pathways involved in the responses induced by leptin alone. We studied the effects of inhibitors of JAK (JAK2 and JAK3), MAPK (Erk1/2, p38, JNK), PKC and NF-kappaB pathways on leptin-induced NO, PGE2, IL-6, and IL-8 production in OA cartilage. There seems to be some differences in the signaling pathways important for production of the four different leptin-induced inflammatory molecules in OA cartilage. Leptin-induced NO production was suppressed by inhibitors of JNK, JAK3, PKC, and NF-kappaB, while leptin-induced PGE2 production was reduced by inhibitors of JNK, p38, and Erk1/2 MAPkinases and transcription factor NF-kappaB. Leptin-induced IL-6 and IL-8 production was reduced by inhibitors of JNK, PKC, and NF-kappaB (Figure 3).
###end p 41
###begin p 42
###xml 175 176 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 272 280 272 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 328 329 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 463 468 <span type="species:ncbi:9606">human</span>
In the present study, inhibition of leptin-induced endogenous NO production in OA cartilage with a selective iNOS inhibitor 1400 W also suppressed the effects of leptin on PGE2, IL-6, and IL-8 production. The effect was reversed with exogenously added NO (NO-donor SNAP) (Figure 4). Those results suggest that leptin induces PGE2, IL-6, and IL-8 production in OA cartilage by an NO-dependent manner. The mediator role of NO in leptin-induced metabolic changes in human OA cartilage has not been reported previously. It is, however, supported by the previous findings on the involvement of NO in the effects of leptin in some other organ systems, that is, in the secretion of luteinizing hormone-releasing hormone from the pituitary gland, in the control of blood pressure, and in the gastroprotection upon vagal activity [60-62].
###end p 42
###begin p 43
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 274 279 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 310 311 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 490 491 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 633 634 629 630 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 337 342 <span type="species:ncbi:9606">human</span>
In conclusion, OA cartilage was shown to respond to leptin by producing increased amounts of NO, PGE2, IL-6, IL-8, and all those effects can be considered harmful in cartilage metabolism. Those effects of leptin seem to be dependent on activation of transcription factor NF-kappaB and the MAPK pathway c-Jun NH2-terminal kinase (JNK) in human OA cartilage. In addition, JAK3 signaling seems to be involved in leptin-induced NO production, p38, and Erk1/2 MAPK pathways in leptin-induced PGE2 production, and PKC pathway in leptin-induced NO, IL-6, and IL-8 production. Inhibition of NO production reduced the effects of leptin on PGE2, IL-6, and IL-8 production pointing to a mediator role of NO in these leptin-induced changes in cartilage metabolism and to a possible beneficial effect of iNOS inhibitors on OA cartilage. These findings support the idea of leptin as a factor in the pathogenesis of osteoarthritis, and as a possible link between obesity and osteoarthritis.
###end p 43
###begin title 44
Acknowledgments
###end title 44
###begin p 45
The excellent technical assistance of Mrs. Marja-Leena Lampen and Mrs. Marja Jousimies and the skilful secretarial help of Mrs. Heli Maatta are acknowledged. The study was supported by the Research Programme on Nutrition, Foods and Health (ELVIRA) of National Technology Agency in Finland, by the Competitive Research Funding of the Pirkanmaa Hospital District, and by the Scandinavian Rheumatology Research Foundation.
###end p 45
###begin article-title 46
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Positional cloning of the mouse obese gene and its human homologue
###end article-title 46
###begin article-title 47
Leptin in immunology
###end article-title 47
###begin article-title 48
Intracellular signalling pathways activated by leptin
###end article-title 48
###begin article-title 49
Role of leptin in immunity
###end article-title 49
###begin article-title 50
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis
###end article-title 50
###begin article-title 51
Osteoarthritis: epidemiology and classification
###end article-title 51
###begin article-title 52
Evidence for a key role of leptin in osteoarthritis
###end article-title 52
###begin article-title 53
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production
###end article-title 53
###begin article-title 54
Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism
###end article-title 54
###begin article-title 55
Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array
###end article-title 55
###begin article-title 56
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human articular chondrocytes express functional leptin receptors
###end article-title 56
###begin article-title 57
###xml 97 102 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 106 111 <span type="species:ncbi:9606">human</span>
Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells
###end article-title 57
###begin article-title 58
Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1
###end article-title 58
###begin article-title 59
Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention
###end article-title 59
###begin article-title 60
The role of nitric oxide in osteoarthritis
###end article-title 60
###begin article-title 61
###xml 110 115 <span type="species:ncbi:9606">human</span>
Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage
###end article-title 61
###begin article-title 62
Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition
###end article-title 62
###begin article-title 63
The role of cytokines in cartilage matrix degeneration in osteoarthritis
###end article-title 63
###begin article-title 64
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
###end article-title 64
###begin article-title 65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
###end article-title 65
###begin article-title 66
Systemic and local regulation of articular cartilage metabolism: where does leptin fit in the puzzle?
###end article-title 66
###begin article-title 67
Nitric oxide activates metalloprotease enzymes in articular cartilage
###end article-title 67
###begin article-title 68
Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors
###end article-title 68
###begin article-title 69
###xml 46 51 <span type="species:ncbi:9606">human</span>
Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture
###end article-title 69
###begin article-title 70
Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1
###end article-title 70
###begin article-title 71
###xml 89 92 <span type="species:ncbi:10116">rat</span>
Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage
###end article-title 71
###begin article-title 72
Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target
###end article-title 72
###begin article-title 73
Chondrocyte apoptosis induced by nitric oxide
###end article-title 73
###begin article-title 74
Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis
###end article-title 74
###begin article-title 75
###xml 41 45 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis
###end article-title 75
###begin article-title 76
###xml 79 84 <span type="species:ncbi:9606">human</span>
The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation
###end article-title 76
###begin article-title 77
Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage: role of endogenous IL-1 inhibitors
###end article-title 77
###begin article-title 78
###xml 73 77 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IRbeta tyrosine phosphorylation
###end article-title 78
###begin article-title 79
###xml 37 42 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes
###end article-title 79
###begin article-title 80
Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase
###end article-title 80
###begin article-title 81
Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level
###end article-title 81
###begin article-title 82
The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide
###end article-title 82
###begin article-title 83
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Animal models of arthritis in NOS2-deficient mice
###end article-title 83
###begin article-title 84
###xml 23 28 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 98 104 <span type="species:ncbi:10090">murine</span>
Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1
###end article-title 84
###begin article-title 85
Leptin-induced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation
###end article-title 85
###begin article-title 86
###xml 89 94 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
Leptin induces nitric oxide synthase type II in C6 glioma cells: role for nuclear factor-kappaB in hormone effect
###end article-title 86
###begin article-title 87
The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism
###end article-title 87
###begin article-title 88
###xml 47 52 <span type="species:ncbi:9606">human</span>
Superinduction of cyclooxygenase-2 activity in human osteoarthritis- affected cartilage. Influence of nitric oxide
###end article-title 88
###begin article-title 89
Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase
###end article-title 89
###begin article-title 90
###xml 81 86 <span type="species:ncbi:9606">human</span>
Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes
###end article-title 90
###begin article-title 91
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
###end article-title 91
###begin article-title 92
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
###end article-title 92
###begin article-title 93
Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation
###end article-title 93
###begin article-title 94
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis
###end article-title 94
###begin article-title 95
Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine
###end article-title 95
###begin article-title 96
###xml 25 29 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 34 39 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 90 95 <span type="species:ncbi:9606">human</span>
Effects of exogenous IL-1beta, TNFalpha, IL-6, and IL-8 and LIF on cytokine production by human articular chondrocytes
###end article-title 96
###begin article-title 97
###xml 61 68 <span type="species:ncbi:9986">rabbits</span>
Neutrophil accumulation and activation by homologous IL-8 in rabbits: IL- 8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo
###end article-title 97
###begin article-title 98
IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage
###end article-title 98
###begin article-title 99
Cytokines as therapeutic targets for osteoarthritis
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Human leptin stimulates proliferation and activation of human circulating monocytes
###end article-title 100
###begin article-title 101
###xml 61 66 <span type="species:ncbi:9606">human</span>
Effects of leptin on the production of cytokines by cultured human endometrial stromal and epithelial cells
###end article-title 101
###begin article-title 102
###xml 48 53 <span type="species:ncbi:9606">human</span>
Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming
###end article-title 102
###begin article-title 103
Leptin signalling
###end article-title 103
###begin article-title 104
Phosphatidylinositol 3-kinase, MEK-1 and p38 mediate leptin/interferon-gamma synergistic NOS type II induction in chondrocytes
###end article-title 104
###begin article-title 105
Nitric oxide mediates leptin-induced luteinizing hormone-releasing hormone (LHRH) and LHRH and leptin-induced LH release from the pituitary gland
###end article-title 105
###begin article-title 106
Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide
###end article-title 106
###begin article-title 107
Pivotal role of nitric oxide in the control of blood pressure after leptin administration
###end article-title 107
###begin p 108
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 242 244 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 255 257 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 461 462 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 824 825 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 864 865 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 908 909 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 931 932 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</italic>
###xml 934 935 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 945 946 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 963 964 959 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 171 176 <span type="species:ncbi:9606">human</span>
###xml 814 822 <span type="species:ncbi:9606">patients</span>
###xml 854 862 <span type="species:ncbi:9606">patients</span>
###xml 898 906 <span type="species:ncbi:9606">patients</span>
The effect of leptin on NO production (a), iNOS protein expression (b), PGE2 production (c), COX-2 protein expression (d), IL-6 production (e), and IL-8 production (f) in human OA cartilage. Cartilage explants were incubated with leptin (0.1 mug/mL or 10 mug/mL) for 48 hours. NO production (a) was measured as nitrite accumulation in the culture medium by Griess reaction. Expression of iNOS protein (b) and COX-2 protein (d) were measured by Western blot. PGE2 production (c) in the culture medium was measured by RIA. Concentrations of IL-6 (e), and IL-8 (f) in the culture medium were measured by ELISA. Results are expressed as pmol/mg cartilage (a), as percentages in comparison with control sample ((b) and (d)) or pg/mg cartilage ((c), (e), and (f)). Values are mean +/- SEM. Samples were collected from 6 patients (n = 6) in (a) and (c), from 3 patients (n = 3) in (b) and (d), and from 7 patients (n = 7) in (e) and (f). #: P < .2, *: P < .05, and * *: P < .01 as compared to control explants incubated in absence of exogenous leptin.
###end p 108
###begin p 109
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 213 217 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 262 266 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 319 321 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 332 334 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 538 539 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 900 901 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 940 941 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 984 985 974 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1007 1008 997 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</italic>
###xml 1010 1011 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1021 1022 1011 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1039 1040 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 171 176 <span type="species:ncbi:9606">human</span>
###xml 890 898 <span type="species:ncbi:9606">patients</span>
###xml 930 938 <span type="species:ncbi:9606">patients</span>
###xml 974 982 <span type="species:ncbi:9606">patients</span>
The effect of leptin on NO production (a), iNOS protein expression (b), PGE2 production (c), COX-2 protein expression (d), IL-6 production (e), and IL-8 production (f) in human OA cartilage in the presence of IL-1beta. Cartilage explants were incubated with IL-1beta (10 pg/mL) alone or in combination with leptin (0.1 mug/mL or 10 mug/mL) for 48 hours. NO production (a) was measured as nitrite accumulation in the culture medium by Griess reaction. Expression of iNOS protein (b) and COX-2 protein (d) were measured by Western blot. PGE2 production (c) in the culture medium was measured by RIA. Concentrations of IL-6 (e) and IL-8 (f) in the culture medium were measured by ELISA. Results are expressed as pmol/mg cartilage (a), as percentages in comparison with control sample ((b) and (d)) or pg/mg cartilage ((c), (e), and (f)). Values are mean +/- SEM. Samples were collected from 6 patients (n = 6) in (a) and (c), from 3 patients (n = 3) in (b) and (d), and from 7 patients (n = 7) in (e) and (f). #: P < .2, *: P < .05, and * *: P < .01.
###end p 109
###begin p 110
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 200 202 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 337 338 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 497 498 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 678 679 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 721 722 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 732 733 729 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 746 747 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 766 767 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 653 661 <span type="species:ncbi:9606">patients</span>
###xml 696 704 <span type="species:ncbi:9606">patients</span>
The effects of signaling pathway inhibitors on leptin induced NO (a), PGE2 (b), IL-6 (c), and IL-8 (d) production in human OA cartilage. Cartilage explants were incubated for 48 hours with leptin (10 mug/mL) and the inhibitor indicated. NO production (a) was measured as nitrite accumulation in the culture medium by Griess reaction. PGE2 production (b) in the culture medium was measured by RIA. Levels of IL-6 (c), and IL-8 (d) in the culture medium were measured by ELISA. Leptin-induced NO/PGE2/IL-6/IL-8 production was set as 100%, and the other values were related to that. The results are expressed as mean +/- SEM. Samples were collected from 7 patients in (a) and (b) (n = 7) and from 6 patients in (c) and (d) (n = 6). *: P < .05, * *: P < .01, and * * *: P < .001 as compared to explants treated with leptin alone.
###end p 110
###begin p 111
###xml 121 123 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 172 173 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 394 395 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 453 454 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 626 627 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 658 659 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 690 691 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 726 727 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 734 735 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</italic>
###xml 737 738 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 752 753 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 609 617 <span type="species:ncbi:9606">patients</span>
###xml 641 649 <span type="species:ncbi:9606">patients</span>
###xml 673 681 <span type="species:ncbi:9606">patients</span>
###xml 709 717 <span type="species:ncbi:9606">patients</span>
The effects of a selective iNOS inhibitor 1400 W (1 mM) ((a)-(d)) with and without NO-donor SNAP ((b)-(d)) on leptin (10 mug/mL) induced NO (a), IL-6 (b), IL-8 (c), and PGE2 (d) production in OA cartilage during 48 hours incubation. In the culture medium, NO production (a) was measured as nitrite accumulation by Griess reaction, levels of IL-6 (b) and IL-8 (c) were measured by ELISA, and PGE2 production (d) was measured by RIA. Leptin-induced NO/PGE2/IL-6/IL-8 production was set as 100%, and the other values were related to that. The results are expressed as mean +/- SEM. Samples were collected from 8 patients in (a) (n = 8), from 6 patients in (b) (n = 6), from 8 patients in (c) (n = 8), and from 6 patients in (d) (n = 6). #: P < .2, * * *: P < .001.
###end p 111

